Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNew navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a refreshed Intervention/Treatment heading appear with a new Revision: v3.6.0 label, while older items (Verified, Last known status was:, Intervention / Treatment, and Revision: v3.5.5) were removed.SummaryDifference1%

- Check16 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous version. This reflects a minor update to the page's documentation/versioning rather than substantive study content.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new build of the page rendering. This appears to be an internal versioning update rather than a modification to the study content.SummaryDifference0.1%

- Check59 days agoChange DetectedClinicalTrials.gov’s page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than study-specific content changes.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision tag was updated from v3.5.0 to v3.5.2. This change does not affect the study content or user interactions.SummaryDifference0.1%

- Check95 days agoChange DetectedUpdated page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.